Currently, most sulfoximine clinical candidates feature both S-aryl and S-alkyl substituents. The asymmetric synthesis of these compounds typically relies on oxidizing corresponding enantioenriched sulfilimines. Herein, we describe an effective catalytic system comprising CuI and an azabicyclo2.2.1 carboxylic acid-derived amide ligand. This system enables the highly enantioselective coupling of S-alkyl sulfenamides with (hetero)aryl iodides to afford aryl alkyl sulfilimines. A wide range of functionalized (hetero)aryl iodides and S-alkyl sulfenamides are compatible under the reaction conditions, providing an attractive approach for assembling enantioenriched aryl alkyl sulfilimines. The utility of this method is demonstrated by the gram-scale asymmetric synthesis of clinical candidate TNG 260 and the formal asymmetric synthesis of three additional drug candidates.
Zhang et al. (Mon,) studied this question.